BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Vries M, Van Rijckevorsel DC, Vissers KC, Wilder-Smith OH, Van Goor H. Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability. Br J Clin Pharmacol 2016;81:525-37. [PMID: 26505163 DOI: 10.1111/bcp.12811] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Campos DA, Mendivil EJ, Romano M, García M, Martínez ME. A Systemic Review of Medical Cannabinoids Dosing in Human. Clinical Therapeutics 2022. [DOI: 10.1016/j.clinthera.2022.10.003] [Reference Citation Analysis]
2 Clarke S, Butcher BE, McLachlan AJ, Henson JD, Rutolo D, Hall S, Vitetta L. Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain. PLoS One 2022;17:e0270543. [PMID: 36240167 DOI: 10.1371/journal.pone.0270543] [Reference Citation Analysis]
3 Bilbao A, Spanagel R. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC Med 2022;20:259. [PMID: 35982439 DOI: 10.1186/s12916-022-02459-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Monfort A, Ferreira E, Leclair G, Lodygensky GA. Pharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and Breastfeeding. Front Pharmacol 2022;13:919630. [DOI: 10.3389/fphar.2022.919630] [Reference Citation Analysis]
5 Nielsen S, Picco L, Murnion B, Winters B, Matheson J, Graham M, Campbell G, Parvaresh L, Khor KE, Betz-Stablein B, Farrell M, Lintzeris N, Le Foll B. Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies. Neuropsychopharmacology 2022. [PMID: 35459926 DOI: 10.1038/s41386-022-01322-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Bogale K, Raup-Konsavage W, Dalessio S, Vrana K, Coates MD. Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease. Med Cannabis Cannabinoids 2021;4:97-106. [PMID: 35224429 DOI: 10.1159/000517425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Azam C, Buscail L, Culetto A, Lapeyre-Mestre M. Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports. Drug Saf 2022. [PMID: 35179705 DOI: 10.1007/s40264-022-01146-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Perito ER, Pohl JF, Bakker C, Armfield MA, Barth B, Cuneo A, Mascarenhas M, Mehta M, Schwarzenberg SJ. Outpatient Pain Management in Children With Chronic Pancreatitis: A Scoping Systematic Review. Pancreas 2022;51:135-47. [DOI: 10.1097/mpa.0000000000001973] [Reference Citation Analysis]
9 Saviano A. Cannabis and Organ Damage: A Focus on Pancreatitis (to Include Different Scenarios). Handbook of Substance Misuse and Addictions 2022. [DOI: 10.1007/978-3-030-67928-6_68-1] [Reference Citation Analysis]
10 Saviano A. Cannabis and Organ Damage: A Focus on Pancreatitis (to Include Different Scenarios). Handbook of Substance Misuse and Addictions 2022. [DOI: 10.1007/978-3-030-92392-1_68] [Reference Citation Analysis]
11 Wang L, Hong PJ, May C, Rehman Y, Oparin Y, Hong CJ, Hong BY, AminiLari M, Gallo L, Kaushal A, Craigie S, Couban RJ, Kum E, Shanthanna H, Price I, Upadhye S, Ware MA, Campbell F, Buchbinder R, Agoritsas T, Busse JW. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ 2021;374:n1034. [PMID: 34497047 DOI: 10.1136/bmj.n1034] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 31.0] [Reference Citation Analysis]
12 Watanabe AH, Navaravong L, Sirilak T, Prasitwarachot R, Nathisuwan S, Page RL 2nd, Chaiyakunapruk N. A systematic review and meta-analysis of randomized controlled trials of cardiovascular toxicity of medical cannabinoids. J Am Pharm Assoc (2003) 2021;61:e1-e13. [PMID: 33952424 DOI: 10.1016/j.japh.2021.03.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Velayudhan L, McGoohan K, Bhattacharyya S. Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis. PLoS Med 2021;18:e1003524. [PMID: 33780450 DOI: 10.1371/journal.pmed.1003524] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
14 Longo R, Oudshoorn A, Befus D. Cannabis for Chronic Pain: A Rapid Systematic Review of Randomized Control Trials. Pain Manag Nurs 2021;22:141-9. [PMID: 33353819 DOI: 10.1016/j.pmn.2020.11.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
15 Gotfried J, Naftali T, Schey R. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease. Gastroenterology 2020;159:62-80. [DOI: 10.1053/j.gastro.2020.03.087] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
16 Poyatos L, Pérez-Acevedo AP, Papaseit E, Pérez-Mañá C, Martin S, Hladun O, Siles A, Torrens M, Busardo FP, Farré M. Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review. Medicina (Kaunas) 2020;56:E309. [PMID: 32585912 DOI: 10.3390/medicina56060309] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
17 Haleem R, Wright R. A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults. J Clin Med Res 2020;12:344-51. [PMID: 32587650 DOI: 10.14740/jocmr4210] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
18 Wong SSC, Chan WS, Cheung CW. Analgesic Effects of Cannabinoids for Chronic Non-cancer Pain: a Systematic Review and Meta-Analysis with Meta-Regression. J Neuroimmune Pharmacol 2020;15:801-29. [PMID: 32172501 DOI: 10.1007/s11481-020-09905-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
19 Mohiuddin MM, Mizubuti GB, Haroutounian S, Smith SM, Rice AS, Campbell F, Park R, Gilron I. Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Medical Cannabis and Cannabis-based Medicines for Chronic Noncancer Pain: A Systematic Review. The Clinical Journal of Pain 2020;36:302-19. [DOI: 10.1097/ajp.0000000000000807] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
20 Shaikh A, Money S. Cannabinoids and Pain Management: an Insight into Recent Advancements. Curr Emerg Hosp Med Rep 2019;7:208-13. [DOI: 10.1007/s40138-019-00199-w] [Reference Citation Analysis]
21 Rabgay K, Waranuch N, Chaiyakunapruk N, Sawangjit R, Ingkaninan K, Dilokthornsakul P. The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis. J Am Pharm Assoc (2003) 2020;60:225-234.e6. [PMID: 31495691 DOI: 10.1016/j.japh.2019.07.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
22 Trouvin A, Perrot S. Cannabis : enjeux et risques en médecine de la douleur. Douleur analg 2019;32:73-78. [DOI: 10.3166/dea-2019-0062] [Reference Citation Analysis]
23 Njei B, Sharma P, McCarty TR, Singh M, Haque L, Aslanian HR, Jamidar P, Muniraj T. Cannabis Use Is Associated With Increased Risk of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Analysis of the US Nationwide Inpatient Sample Database, 2004-2014. Pancreas 2018;47:1142-9. [PMID: 30134357 DOI: 10.1097/MPA.0000000000001143] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
24 Campbell G, Stockings E, Nielsen S. Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. Eur Arch Psychiatry Clin Neurosci 2019;269:135-44. [PMID: 30635715 DOI: 10.1007/s00406-018-0960-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
25 Mouhamed Y, Vishnyakov A, Qorri B, Sambi M, Frank SS, Nowierski C, Lamba A, Bhatti U, Szewczuk MR. Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. Drug Healthc Patient Saf 2018;10:45-66. [PMID: 29928146 DOI: 10.2147/DHPS.S158592] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
26 Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, Murnion B, Farrell M, Weier M, Degenhardt L. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain 2018;159:1932-54. [DOI: 10.1097/j.pain.0000000000001293] [Cited by in Crossref: 240] [Cited by in F6Publishing: 248] [Article Influence: 60.0] [Reference Citation Analysis]
27 Pergolizzi JV Jr, Lequang JA, Taylor R Jr, Raffa RB, Colucci D; NEMA Research Group. The role of cannabinoids in pain control: the good, the bad, and the ugly. Minerva Anestesiol 2018;84:955-69. [PMID: 29338150 DOI: 10.23736/S0375-9393.18.12287-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
28 Goyal H, Guerreso K, Smith B, Harper K, Patel S, Patel A, Parikh P. Severity and outcomes of acute alcoholic pancreatitis in cannabis users. Transl Gastroenterol Hepatol 2017;2:60. [PMID: 28815220 DOI: 10.21037/tgh.2017.06.03] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
29 Goyal H, Singla U, Gupta U, May E. Role of cannabis in digestive disorders. Eur J Gastroenterol Hepatol. 2017;29:135-143. [PMID: 27792038 DOI: 10.1097/meg.0000000000000779] [Cited by in Crossref: 59] [Cited by in F6Publishing: 68] [Article Influence: 11.8] [Reference Citation Analysis]
30 de Vries M, van Rijckevorsel DC, Vissers KC, Wilder-smith OH, van Goor H. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study. Clinical Gastroenterology and Hepatology 2017;15:1079-1086.e4. [DOI: 10.1016/j.cgh.2016.09.147] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 8.4] [Reference Citation Analysis]
31 Anchi P, Khurana A, Bale S, Godugu C. The Role of Plant-derived Products in Pancreatitis: Experimental and Clinical Evidence: Plant-derived Products in Pancreatitis. Phytother Res 2017;31:591-623. [DOI: 10.1002/ptr.5792] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
32 de Vries M, Van Rijckevorsel DC, Vissers KC, Wilder-Smith OH, Van Goor H. Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability. Br J Clin Pharmacol 2016;81:525-37. [PMID: 26505163 DOI: 10.1111/bcp.12811] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]